Serum vascular endothelial growth factor as a tumor marker for hepatocellular carcinoma in hepatitis C virus-related cirrhotic patients

doi:10.4251/wjgo.v13.i6.600

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3961)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-9) series.

Item

Count

PDF

205

WORD

HTML

2027

Figures (1-2)

231

Tables (1-9)

213

Sum=2767

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

384

Download

810

Sum=1194

Jun 15, 2021 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastrointest Oncol. Jun 15, 2021; 13(6): 600-611
Published online Jun 15, 2021. doi: 10.4251/wjgo.v13.i6.600

Table 7 Correlation between serum alpha fetoprotein and vascular endothelial growth factor levels among hepatocellular carcinoma cases

	AFP (ng/mL)
	r	P value
VEGF (pg/mL)	0.119	0.463¹

¹Spearman correlation coefficients.

AFP: Alpha fetoprotein; VEGF: Vascular endothelial growth factor.

Citation: Alzamzamy A, Elsayed H, Abd Elraouf M, Eltoukhy H, Megahed T, Aboubakr A. Serum vascular endothelial growth factor as a tumor marker for hepatocellular carcinoma in hepatitis C virus-related cirrhotic patients. World J Gastrointest Oncol 2021; 13(6): 600-611
URL: https://www.wjgnet.com/1948-5204/full/v13/i6/600.htm
DOI: https://dx.doi.org/10.4251/wjgo.v13.i6.600